関連する実験動画

Updated: Sep 9, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

潜在的なEGFR阻害体としてのキラル1,3,5-トリアジン:薬剤分解モデル化,合成,分子ドッキング,分子動態シミュレーション,および抗がん評価

Saravanakumar Natarajan¹, Latha Ganesapandian^1,2, Pandeeshwaran Santhoshkumar¹

¹Supramolecular and Catalysis Lab, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, India.

Chemistry & biodiversity

|August 29, 2025

まとめ

乳がんと肺がんにおける表皮成長因子受容体 (EGFR) 信号伝達を標的として開発された. 最も強力な化合物は,EGFRを標的とするがん治療の有望性を示した.

科学分野:

薬剤化学
腫瘍学
薬剤設計

背景:

Epidermal成長因子受容体 (EGFR) のシグナリングは,乳がんと肺がんの主要な標的である.
改善された有効性と選択性を持つ新しい阻害剤の開発は,がん治療に不可欠です.

研究の目的:

EGFRの潜在的阻害剤としてキラル1,3,5-トリアジン誘導体のライブラリを設計し,合成する.
乳がん (MCF-7) と肺がん (A549) 細胞系に対するこれらの化合物の抗がん活性を評価する.

主な方法:

立体構造の設計に利用されたリガンドベースの薬剤設計アプローチ.
キラル-1,3,5-トリアジン誘導体の合成プロトコルを最適化しました.
EGFR- TKのATP結合部位での分子ドッキング.

主要な成果:

体系的な構造変更により,物理化学的およびADMEの性能が微調整されました.
EGFR抑制活性と相関する分子ドッキング.
(R) - 4 - 3 - 4 - 3 - メトキシフェノキシ) - 6 - 3 - ピロリジン - 3 - イラミノ) - 1 , 3 , 5 - トリアジン - 2 - アミノ) ベンゾニトリル (13c) は強力な細胞毒性を示した (IC50: MCF - 7 に対して 8. 04 μM,A549 に対して 12. 24 μM).

結論:

チラルの1,3,5-トリアジンは,EGFRを標的とする新しいがん治療薬の開発に有望な基幹です.
合成された化合物は,腫瘍学におけるさらなる開発の有意な可能性を示しています.

キーワード:

EGFRの抑制活動キラル-1,3,5-トリアジンコモン・ファルマコフォアリガンドベースの設計

さらに関連する動画

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

関連する概念動画

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Chirality in Nature

Chirality in Nature

Chirality is the most intriguing yet essential facet of nature, governing life’s biochemical processes and precision. It can be observed from a snail shell pattern in a macroscopic world to an amino acid, the minutest building block of life. Most of the snails around the world have right-coiled shells because of the intrinsic chirality in their genes. All the amino acids present in the human body exist in an enantiomerically pure state, except for glycine - the sole achiral amino acid.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...